Global Sofosbuvir (CAS 1190307-88-0) Market Research Report 2021
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Research Predicts that Sofosbuvir (CAS 1190307-88-0) Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Sofosbuvir (CAS 1190307-88-0) Market Overview:
Global Sofosbuvir (CAS 1190307-88-0) Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Sofosbuvir (CAS 1190307-88-0) involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Sofosbuvir (CAS 1190307-88-0) Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Sofosbuvir (CAS 1190307-88-0) market in 2020.
Global Sofosbuvir (CAS 1190307-88-0) Market Segmentation
By Type, Sofosbuvir (CAS 1190307-88-0) market has been segmented into:
Purity ≥ 98%
Purity ＜ 98%
By Application, Sofosbuvir (CAS 1190307-88-0) market has been segmented into:
Adults Patients
Elderly Patients
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Sofosbuvir (CAS 1190307-88-0) market are:
Teva Pharmaceutical Industries Ltd
DONG BANG FUTURE TECH & LIFE CO. Ltd
Beaukev Pharma International Pvt.Ltd
DEAFARMA
Tecoland
Anhui HaiKang Pharmaceutical Co. Ltd
Shanghai Haoyuan Chemexpress Co. Ltd
Beijing Kawin Technology Share-holding Co
Hangzhou Longshine Bio-Tech Co
1. Market Overview of Sofosbuvir (CAS 1190307-88-0)
1.1 Sofosbuvir (CAS 1190307-88-0) Market Overview
1.1.1 Sofosbuvir (CAS 1190307-88-0) Product Scope
1.1.2 Market Status and Outlook
1.2 Sofosbuvir (CAS 1190307-88-0) Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Sofosbuvir (CAS 1190307-88-0) Historic Market Size by Regions (2015-2020)
1.4 Sofosbuvir (CAS 1190307-88-0) Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Sofosbuvir (CAS 1190307-88-0) Sales Market by Type (2015-2026)
2.1 Global Sofosbuvir (CAS 1190307-88-0) Historic Market Size by Type (2015-2020)
2.2 Global Sofosbuvir (CAS 1190307-88-0) Forecasted Market Size by Type (2021-2026)
2.3 Purity ≥ 98%
2.4 Purity ＜ 98%
3. Covid-19 Impact Sofosbuvir (CAS 1190307-88-0) Sales Market by Application (2015-2026)
3.1 Global Sofosbuvir (CAS 1190307-88-0) Historic Market Size by Application (2015-2020)
3.2 Global Sofosbuvir (CAS 1190307-88-0) Forecasted Market Size by Application (2021-2026)
3.3 Adults Patients
3.4 Elderly Patients
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Sofosbuvir (CAS 1190307-88-0) Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Sofosbuvir (CAS 1190307-88-0) Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Sofosbuvir (CAS 1190307-88-0) Business
5.1 Teva Pharmaceutical Industries Ltd
5.1.1 Teva Pharmaceutical Industries Ltd Company Profile
5.1.2 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Product Specification
5.1.3 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 DONG BANG FUTURE TECH & LIFE CO. Ltd
5.2.1 DONG BANG FUTURE TECH & LIFE CO. Ltd Company Profile
5.2.2 DONG BANG FUTURE TECH & LIFE CO. Ltd Sofosbuvir (CAS 1190307-88-0) Product Specification
5.2.3 DONG BANG FUTURE TECH & LIFE CO. Ltd Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Beaukev Pharma International Pvt.Ltd
5.3.1 Beaukev Pharma International Pvt.Ltd Company Profile
5.3.2 Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Product Specification
5.3.3 Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 DEAFARMA
5.4.1 DEAFARMA Company Profile
5.4.2 DEAFARMA Sofosbuvir (CAS 1190307-88-0) Product Specification
5.4.3 DEAFARMA Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Tecoland
5.5.1 Tecoland Company Profile
5.5.2 Tecoland Sofosbuvir (CAS 1190307-88-0) Product Specification
5.5.3 Tecoland Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Anhui HaiKang Pharmaceutical Co. Ltd
5.6.1 Anhui HaiKang Pharmaceutical Co. Ltd Company Profile
5.6.2 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Product Specification
5.6.3 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Shanghai Haoyuan Chemexpress Co. Ltd
5.7.1 Shanghai Haoyuan Chemexpress Co. Ltd Company Profile
5.7.2 Shanghai Haoyuan Chemexpress Co. Ltd Sofosbuvir (CAS 1190307-88-0) Product Specification
5.7.3 Shanghai Haoyuan Chemexpress Co. Ltd Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Beijing Kawin Technology Share-holding Co
5.8.1 Beijing Kawin Technology Share-holding Co Company Profile
5.8.2 Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Product Specification
5.8.3 Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Hangzhou Longshine Bio-Tech Co
5.9.1 Hangzhou Longshine Bio-Tech Co Company Profile
5.9.2 Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Product Specification
5.9.3 Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Sofosbuvir (CAS 1190307-88-0) Market Size (2015-2026)
6.2 North America Sofosbuvir (CAS 1190307-88-0) Key Players in North America (2015-2020)
6.3 North America Sofosbuvir (CAS 1190307-88-0) Market Size by Type (2015-2020)
6.4 North America Sofosbuvir (CAS 1190307-88-0) Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Sofosbuvir (CAS 1190307-88-0) Market Size (2015-2026)
7.2 East Asia Sofosbuvir (CAS 1190307-88-0) Key Players in North America (2015-2020)
7.3 East Asia Sofosbuvir (CAS 1190307-88-0) Market Size by Type (2015-2020)
7.4 East Asia Sofosbuvir (CAS 1190307-88-0) Market Size by Application (2015-2020)
8. Europe
8.1 Europe Sofosbuvir (CAS 1190307-88-0) Market Size (2015-2026)
8.2 Europe Sofosbuvir (CAS 1190307-88-0) Key Players in North America (2015-2020)
8.3 Europe Sofosbuvir (CAS 1190307-88-0) Market Size by Type (2015-2020)
8.4 Europe Sofosbuvir (CAS 1190307-88-0) Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Sofosbuvir (CAS 1190307-88-0) Market Size (2015-2026)
9.2 South Asia Sofosbuvir (CAS 1190307-88-0) Key Players in North America (2015-2020)
9.3 South Asia Sofosbuvir (CAS 1190307-88-0) Market Size by Type (2015-2020)
9.4 South Asia Sofosbuvir (CAS 1190307-88-0) Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Sofosbuvir (CAS 1190307-88-0) Market Size (2015-2026)
10.2 Southeast Asia Sofosbuvir (CAS 1190307-88-0) Key Players in North America (2015-2020)
10.3 Southeast Asia Sofosbuvir (CAS 1190307-88-0) Market Size by Type (2015-2020)
10.4 Southeast Asia Sofosbuvir (CAS 1190307-88-0) Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Sofosbuvir (CAS 1190307-88-0) Market Size (2015-2026)
11.2 Middle East Sofosbuvir (CAS 1190307-88-0) Key Players in North America (2015-2020)
11.3 Middle East Sofosbuvir (CAS 1190307-88-0) Market Size by Type (2015-2020)
11.4 Middle East Sofosbuvir (CAS 1190307-88-0) Market Size by Application (2015-2020)
12. Africa
12.1 Africa Sofosbuvir (CAS 1190307-88-0) Market Size (2015-2026)
12.2 Africa Sofosbuvir (CAS 1190307-88-0) Key Players in North America (2015-2020)
12.3 Africa Sofosbuvir (CAS 1190307-88-0) Market Size by Type (2015-2020)
12.4 Africa Sofosbuvir (CAS 1190307-88-0) Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Sofosbuvir (CAS 1190307-88-0) Market Size (2015-2026)
13.2 Oceania Sofosbuvir (CAS 1190307-88-0) Key Players in North America (2015-2020)
13.3 Oceania Sofosbuvir (CAS 1190307-88-0) Market Size by Type (2015-2020)
13.4 Oceania Sofosbuvir (CAS 1190307-88-0) Market Size by Application (2015-2020)
14. South America
14.1 South America Sofosbuvir (CAS 1190307-88-0) Market Size (2015-2026)
14.2 South America Sofosbuvir (CAS 1190307-88-0) Key Players in North America (2015-2020)
14.3 South America Sofosbuvir (CAS 1190307-88-0) Market Size by Type (2015-2020)
14.4 South America Sofosbuvir (CAS 1190307-88-0) Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Sofosbuvir (CAS 1190307-88-0) Market Size (2015-2026)
15.2 Rest of the World Sofosbuvir (CAS 1190307-88-0) Key Players in North America (2015-2020)
15.3 Rest of the World Sofosbuvir (CAS 1190307-88-0) Market Size by Type (2015-2020)
15.4 Rest of the World Sofosbuvir (CAS 1190307-88-0) Market Size by Application (2015-2020)
16 Sofosbuvir (CAS 1190307-88-0) Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Research Methodology:
Sofosbuvir (CAS 107 88 0) Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|